Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Caryn A Libbey, M.D.

Concepts (68)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Amyloidosis820118770.220 Why?
Gout220206210.210 Why?
Gout Suppressants220201760.180 Why?
Uricosuric Agents12020300.180 Why?
Tattooing12000570.170 Why?
Arthritis120236840.140 Why?
Peripheral Nervous System Diseases120237160.140 Why?
Vasculitis120005250.130 Why?
Rheumatology120206170.110 Why?
Immunoglobulin Light Chains120112890.090 Why?
Colchicine320202570.080 Why?
Stem Cell Transplantation2201115990.080 Why?
Melphalan220044210.080 Why?
Prealbumin219852590.060 Why?
Polyneuropathies119841390.050 Why?
Hepatitis C Antigens12000340.040 Why?
Naltrexone120233190.040 Why?
Hepatitis B Core Antigens12000900.040 Why?
Cryoglobulinemia12000840.040 Why?
Blood Sedimentation120002360.040 Why?
Allopurinol120202020.040 Why?
Aspartate Aminotransferases120004140.040 Why?
Alanine Transaminase120006060.040 Why?
Abdomen1198311360.040 Why?
Fatigue1202315570.030 Why?
Transplantation, Autologous2201121250.030 Why?
Antineoplastic Agents, Alkylating119966140.020 Why?
Biopsy2200067920.020 Why?
Kidney Diseases1198221000.020 Why?
Adipose Tissue1198333340.020 Why?
Prednisone1199615670.020 Why?
Anti-Inflammatory Agents, Non-Steroidal1202022710.020 Why?
Pilot Projects1202387410.020 Why?
Disease Management1202025350.020 Why?
Double-Blind Method12023124660.020 Why?
Skin1200045050.020 Why?
Anti-Inflammatory Agents1199618100.020 Why?
Texas119844100.010 Why?
England119845330.010 Why?
Humans1220237681710.010 Why?
Germany119848830.010 Why?
Quality of Life12023134900.010 Why?
Combined Modality Therapy1201185420.010 Why?
Staining and Labeling1198310800.010 Why?
Dose-Response Relationship, Drug12011107630.010 Why?
Treatment Outcome22023653790.010 Why?
Biopsy, Needle1198316230.010 Why?
Survival Analysis22004100990.010 Why?
Survival Rate12011128400.010 Why?
Pedigree1198445390.010 Why?
Middle Aged520042234870.010 Why?
Female620043971870.010 Why?
United States12020730390.010 Why?
Longitudinal Studies12004147830.000 Why?
Kidney1198270640.000 Why?
Age Factors11984184150.000 Why?
Drug Therapy, Combination1199663160.000 Why?
Cause of Death1199637210.000 Why?
Time Factors21987402200.000 Why?
Retinol-Binding Proteins11985670.000 Why?
Serum Amyloid A Protein119851280.000 Why?
Risk2198796130.000 Why?
Aged220041715020.000 Why?
Male420043647310.000 Why?
Life Expectancy1198712480.000 Why?
Adolescent11982891690.000 Why?
Sex Factors11987106320.000 Why?
Prognosis11987300090.000 Why?
Libbey's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (68)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.